Derek Adams
Directeur/Membre du Conseil chez ALLOVIR, INC.
Fortune : 52 850 $ au 31/05/2024
Postes actifs de Derek Adams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALLOVIR, INC. | Directeur/Membre du Conseil | 01/03/2023 | - |
| Independent Dir/Board Member | 01/03/2023 | - |
Historique de carrière de Derek Adams
Anciens postes connus de Derek Adams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Directeur Général | 01/03/2022 | 01/11/2022 |
| Directeur des opérations | 08/07/2021 | - | |
| President | 01/03/2022 | 01/11/2022 | |
| BLUEBIRD BIO, INC. | Directeur Technique/Scientifique/R&D | 20/03/2017 | 01/07/2021 |
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 01/02/2016 | 01/06/2016 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2015 | 01/02/2016 |
Formation de Derek Adams
| University of Minnesota | Doctorate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Bourse
- Insiders
- Derek Adams
- Expérience
